3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with dan 2163 in 1 studies
| Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Studies (dan 2163) | Trials (dan 2163) | Recent Studies (post-2010) (dan 2163) |
|---|---|---|---|---|---|
| 330 | 40 | 33 | 841 | 189 | 342 |
| Protein | Taxonomy | 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide (IC50) | dan 2163 (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 0.003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerner, R; Dresel, S; Frodl, T; Gründer, G; Hahn, K; la Fougère, C; Meisenzahl, EM; Möller, HJ; Scheuerecker, J; Schmitt, G; Schwarz, M; Stauss, J | 1 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and dan 2163
| Article | Year |
|---|---|
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Corpus Striatum; Dose-Response Relationship, Drug; Female; Humans; Iodine Radioisotopes; Male; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Tomography, Emission-Computed, Single-Photon | 2008 |